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Abstract
The heterotrimeric G protein subunit Gsα couples receptors to activate adenylyl cyclase
and is required for the intracellular cAMP response and protein kinase A (PKA) activation.
Gsα is ubiquitously expressed in many cell types; however, the role of Gsα in neural crest
cells (NCCs) remains unclear. Here we report that NCCs-specificGsα knockout mice die
within hours after birth and exhibit dramatic craniofacial malformations, including hypoplas-
tic maxilla and mandible, cleft palate and craniofacial skeleton defects. Histological and
anatomical analysis reveal that the cleft palate inGsα knockout mice is a secondary defect
resulting from craniofacial skeleton deficiencies. InGsα knockout mice, the morphologies of
NCCs-derived cranial nerves are normal, but the development of dorsal root and sympa-
thetic ganglia are impaired. Furthermore, loss ofGsα in NCCs does not affect cranial NCCs
migration or cell proliferation, but significantly accelerate osteochondrogenic differentiation.
Taken together, our study suggests that Gsα is required for neural crest cells-derived cra-
niofacial development.
Introduction
Neural crest cells (NCCs) are transient population of multipotent progenitors which arise from
the border between neural plate and epidermis. During neurulation, NCCs undergo an epithe-
lium to mesenchyme transition (EMT) process, migrate stereotypically to different locations,
then differentiate into multiple cell types [1,2,3,4,5,6,7]. Cranial NCCs, which originate from
posterior forebrain and posterior hindbrain, contribute to bones, cartilages, connective tissues
and cranial ganglia in face and neck. Cardiac NCCs, a subpopulation of cranial NCCs emanat-
ing from rhombomeres 6–8, give rise to parts of cardiac septum, thyroid and thymus. Trunk
NCCs arising from caudal to the fourth somite are necessary for the formation of enteric
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peripheral nervous system (PNS), endocrine organs, pigment cells, as well as dorsal root gan-
glion (DRG) and sympathetic ganglion in PNS. In mammals, craniofacial morphogenesis
requires accurate coordination of cranial NCCs migration, proliferation, apoptosis and differ-
entiation. Disruption of these cellular programs would cause numerous congenital defects
including craniofacial malformations, which comprise at least one-third of human birth defects
[4,8]. Clefts of lip and/or palate (CLP) are the most common craniofacial defects, occurring
approximately 1 in 700 neonates [9].
The α subunit of heterotrimeric G protein (Gsα) is encoded by GNAS (Gnas in mice),
which is ubiquitously expressed in many cell types and responsible for receptor-stimulated
cAMP generation and activation of protein kinase A (PKA) pathway [10,11]. Gnas homozy-
gous mutation in mice causes embryonic lethality; Gnas heterozygous with the inheritance
of maternal or paternal mutation exhibit distinct phenotypes including neurological abnor-
malities, lethality after birth and small with narrow bodies [12]. It has been shown that Gsα
mutations cause skeletal disorders in humans and mice. Heterozygous loss-of-function
mutations in GNAS lead to Albright hereditary osteodystrophy (AHO), which is character-
ized by short stature, brachydactyly, developmental delay or mental deficits, and facial
defects such as orbital hypertelorism and depressed nasal bridge. In contrast, mutations acti-
vating GNAS result in McCune–Albright syndrome (MAS). The MAS patients exhibit
fibrous dysplasia lesions, which is characterized by weakened osteoblast differentiation
[11,13,14,15,16,17]. In mice, chondrocyte-specific ablation of Gsα leads to growth plate
defects and hypertrophic differentiation of growth plate cartilages [18,19]. In mice osteopro-
genitors, loss of Gsα signaling decreased the commitment of mesenchymal progenitors to
osteoblast lineage and accelerated osteogenic differentiation [20]. In addition, Sakamoto
and colleagues reported that the deletion of Gsα in differentiated osteoblast resulted in
reduced trabecular bone volume, increased cortical bone thickness and abnormalities in cra-
niofacial skeleton [21]. Together, these findings indicate that Gsα signaling is crucial for
skeletal formation; however, its role in cranial NCCs-derived craniofacial skeletal develop-
ment has not been investigated.
In the present study, we examined the potential function of Gsα in craniofacial development
usingWnt1-cre-mediated Gsα knockout (KO) mice. NCCs-specific knockout Gsα results in
respiratory distress, inability to suckle and postnatal death in mice. Histological examinations
show thatWnt1-cre;Gsαf/f mutant exhibits craniofacial skeletal defects and cleft palate, prema-
ture ossification within maxilla and mandible, nasal septum, hyoid and laryngeal cartilages, as
well as impaired development of dorsal root and sympathetic ganglia. Further results reveal
that the cleft palate phenotype inWnt1-cre;Gsαf/f mutant is a secondary defect caused by cra-
niofacial skeletal deficiencies. Cellular function analysis shows that the cranial NCCs migration
and cell proliferation are normal, but the osteochondrogenic differentiation is accelerated in
Wnt1-cre;Gsαf/f mutant. Altogether, these results demonstrate that Gsα plays a critical function
in the development of cranial neural crest cells.
Results
Specific deletion ofGsα in NCCs leads to craniofacial malformations,
defective development of dorsal root and sympathetic ganglia
To establish the requirement for Gsα in NCC-derived tissues, Gsαflox/flox mice [22] were crossed
with Wnt1-cre mice in which Cre recombinase is expressed in migrating NCCs [23].Wnt1-cre;
Gsαf/f mutant mice were born at expected Mendelian ratios, but were unable to suckle and pro-
gressively became more cyanotic, and all neonates died within hours after birth. Prenatal lethal-
ity was not observed. All these mutants exhibited severe craniofacial abnormalities at postnatal
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day 0 (P0), including domed skull, shortened maxilla and mandible, and exposed tongue
(Fig 1A). To define the progressive development process inWnt1-cre;Gsαf/fmutants, embryos
from different stages were examined by anatomical analysis. At embryonic day 10.5 and 12.5
(E10.5 and E12.5), the gross morphologies ofWnt1-cre;Gsαf/f mutants and controls were simi-
lar (Fig 1C–1F). However, the E14.5Wnt1-cre;Gsαf/f embryos displayed short snout, round
face and orbital hypertelorism (Fig 1G). The craniofacial abnormalities were severer at later
embryonic stages, as shown by the maxilla and mandible in E16.5 and E18.5Wnt1-cre;Gsαf/f
embryos were dramatically shortened which leads to extended tongues (Fig 1I and 1K). Next,
to determine the effect of Gsα on cranial nerves morphogenesis, E10.5 and E12.5 embryos were
immunostained with anti-neurofilament antibody. The formation of cranial nerves was normal
in E10.5 and E12.5Wnt1-cre;Gsαf/f embryos compared to controls (Fig A-D in S1 Fig). To ana-
lyze the effects of Gsα deletion in NCCs-derived cardiac, DRG and sympathetic development,
we crossed Gsαflox/flox mice with Rosa26-reporter transgenic mice to generateWnt1-cre;Gsαf/f;
R26Rmutants. All theseWnt1-cre;Gsαf/f;R26Rmutants also exhibited craniofacial malforma-
tions and cleft palates. Whole-mount X-gal staining results showed the gross morphologies of
outflow tract and cardiac development were similar between E17.5Wnt1-cre;Gsαf/f and con-
trols (Fig E and F in S1 Fig). The formation of DRG and sympathetic ganglia in E15.5 mutants
were normal (Fig A and B in S2 Fig), but reduced size of DRG and sympathetic ganglia were
observed in E16.5 and E17.5 mutants (Fig C-J in S2 Fig). Together, these results indicate that
loss of Gsα in NCCs leads to craniofacial malformations, defective development of DRG and
sympathetic ganglia.
Wnt1-cre;Gsαf/fmutants exhibit craniofacial skeletal defects
To analyze the effect of Gsα loss on craniofacial structures, skeletal preparation from newborn
Wnt1-cre;Gsαf/f mutants and controls were stained with Alcian Blue and Alizarin Red to reveal
cartilages and bones, respectively. A suture between frontal bones was observed in control, but
it was abnormally fused inWnt1-cre;Gsαf/f mutant (Fig 2A and 2B). In mutant, the cartilage of
nasal capsule (nc) was absent, the maxilla(x), premaxilla (px) and mandible (ma) were hypo-
plastic and malformed (Fig 2C), and the tympanic ring (tr) and body of hyoid bone (b-hy)
exhibited abnormal ossification (Fig 2E) compared to that in control (Fig 2D and 2F). Interest-
ingly, the nasal capsule, maxilla, premaxilla, mandible, tympanic ring and body of hyoid bone,
which are assigned NCCs originals, were absent or severely malformed, whereas the skeleton
elements from mesoderm including parietal (pr), lateral portion of the interparietal (ip),
supraoccipital (so), exoccipital (eo), basioccipital (bo) and otic capsule (oc), were formed nor-
mally inWnt1-cre;Gsαf/f mutant (Fig 2C–2F). The bilateral palatal bones extended horizontally
and eventually fused to form palate in control, but they were hypoplastic and thus palate was
cleft in mutant (Fig 2G and 2H).
Given that the hyoid bone and mandibular bone in P0Wnt1-cre;Gsαf/f mutant were heavily
ossified (Fig 2E), to further define this defect, we observed the hyoid and laryngeal skeletons
and mandible isolated from different stages. The appearance of laryngeal skeletons in
Wnt1-cre;Gsαf/f mutant were normal until E14.5 (Fig 2I), but starting from E15.5, the prema-
ture ossification in body of hyoid bone was observed (Fig 2J). This abnormal ossification in P0
Wnt1-cre;Gsαf/f mutant was much more severe than that in control (Fig 2K). Additionally, dis-
sected mandibles from the same E14.5 and E15.5 embryos shown in Fig 2I and 2J revealed that
Wnt1-cre;Gsαf/f mutants exhibited abnormal ossification in the incisor tip (Fig 2L and 2M).
Moreover, the appearance of mandibular bone in P0 mutant was dramatically malformed; and
the condylar, coronoid and angular processes (cdp, crp and agp) in mutant mandible were
missing compared to that in control (Fig 2N).
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Fig 1. Loss ofGsα in NCCs results in severe craniofacial malformations. (A, B) P0Wnt1-cre;Gsαf/f
mutant and control.Wnt1-cre;Gsαf/fmutant mice become cyanotic and die within hours after birth, exhibit
domed skull, shortened maxilla and mandible and exposed tongue. (C-F) The gross appearance ofWnt1-cre;
Gsαf/fmutants (C and E) and controls (D and F) are identical at E10.5 and E12.5 respectively. (G, H) E14.5
Wnt1-cre;Gsαf/fmutant and control.Wnt1-cre;Gsαf/f embryos show short snout, round face and
hypertelorism. (I-L) E16.5 and E18.5Wnt1-cre;Gsαf/fmutants (I and K) display exposed tongues and
shortened maxilla and mandible compare to controls (J and L).
doi:10.1371/journal.pone.0147535.g001
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Fig 2. Wnt1-cre;Gsαf/fmutants exhibit craniofacial skeleton defects. (A-F) Neonates skeleton preparations of newbornWnt1-cre;Gsαf/fmutant and
control stained with alcian blue and alizarin red; dorsal (A, B), lateral (C, D) and ventral (E, F) views. A suture between frontal bones in control (asterisk in B),
but craniosynostosis (A, arrowhead) inWnt1-cre;Gsαf/fmutant. (C-F) InWnt1-cre;Gsαf/fmutant, the premaxilla(pmx), maxilla (mx) and mandible (ma) are
hypoplastic and deformed, the nasal capsule cartilage (nc) is missing, the body of hyoid bone (b-hy) is over-ossified, and the tympanic rings are thickened
and deformed. (G, H) The mandible is removed to enhance the view of palatal bone. Palatal bones are fused to form the secondary palate in control (H,
dashed line), but severely hypoplastic and cleft inWnt1-cre;Gsαf/fmutant (G, dashed lines and asterisk). (I-K) Dissected hyoid and laryngeal skeletons from
E14.5 (I), E15.5 (J), and P0 (K) skeletal staining samples.Wnt1-cre;Gsαf/fmutants exhibit premature ossification in the body of hyoid bone at E15.5, and
abnormal ossification in hyoid bone and thyroid cartilage at P0. (L-N) Dissected mandibles from the same embryos shown in Fig 2 I-K. Arrowheads in (L) and
(M) indicate the abnormal ossification of incisor tip inWnt1-cre;Gsαf/fmutants. The NCCs-derived mandible and tympanic rings are severely malformed, but
Gsα and Craniofacial Morphogenesis
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Taken together, our data indicate that Gsα expression in NCCs is required for the develop-
ment of craniofacial skeleton.
Cleft palate inWnt1-cre;Gsαf/fmutant is caused by craniofacial skeleton
defects
Wnt1-cre;Gsαf/f mutants displayed non-fusion of palatal bones, therefore we removed mandi-
ble and found that the newbornWnt1-cre;Gsαf/f mutant had a complete cleft palate (Fig 3A).
To determine the onset of cleft palate in mutant, palates from different embryonic stages were
examined by histological staining. In controls, the palatal shelves arose from maxillary promi-
nence at E12.5 (Fig 3D) and descended vertically down to the two sides of tongue at E13.5 (Fig
3F), then they elevated to the horizontal position above tongue and elongated to fuse with rem-
nant medial edge epithelium (MEE) at E14.5 (Fig 3H). Finally, the control mice displayed
fused palates with flat tongues (Fig 3J and 3L). In contrast, this progressive process was dis-
rupted by the loss of Gsα. The palatal shelves in mutant were well developed and properly ele-
vated to the horizontal position above tongue (Fig 3C, 3E and 3G), but they failed to elongate
or fuse at E14.5 (Fig 3G), and consequently the E16.5 and E18.5 mutant exhibited cleft palates
with protuberant tongues (Fig 3I and 3K).
The cleft palate phenotype inWnt1-cre;Gsαf/f mutant was tightly accompanied with dra-
matic craniofacial skeleton defects, therefore raising a question that whether the cleft palate
resulted from a primary defect in palatal development or was secondary to craniofacial skeleton
defects. To this end, we examined the fusion ability of palatal shelves by performing an in vitro
palatal shelf organ culture experiment. In brief, each pair of palatal shelves was dissected from
E13.5 embryos and placed on Millipore filters with touching. By 72 hours in culture, all palatal
specimens from controls and mutants showed complete fusion with normal disappearance of
MEE (Fig 3M and 3N), suggesting that palatal shelves inWnt1-cre;Gsαf/f mutants retain the
ability to fuse. Given thatWnt1-cre-mediated deletion of Gsα occurs both in NCCs-derived
craniofacial skeletons and palatal mesenchyme, to ablate Gsα in the mesenchyme and epithe-
lium of palatal shelves but not in craniofacial skeletons, we generated Nestin-cre;Gsαf/f mutants
by crossbreeding Gsαflox/flox mice with Nestin-cremice [24]. Morphological analysis showed
that the newborn Nestin-cre;Gsαf/f mutants displayed normal craniofacial structures and
completely fused palates (data not shown), suggesting that the deletion of Gsα in mesenchyme
and epithelium of palatal shelves does not cause cleft palate. Collectively, these results strongly
suggest that the cleft palate inWnt1-cre;Gsαf/fmutant is not caused by intrinsic defects within
palate but most probably is secondary to craniofacial skeleton defects.
Specific deletion ofGsα in NCCs does not affect CNCCs migration or
cell proliferation
To figure out the possible cellular mechanisms responsible for craniofacial defects inWnt1-cre;
Gsαf/f mutant, we first examine whether Gsα regulates CNCCs migration. Whole-mount X-gal
staining in E9.5 and E14.5 embryos showed a similar CNCCs migration and distribution to
frontonasal prominence (FNP), first branchial arch (BA1), and second branchial arch (BA2)
betweenWnt1-cre;Gsαf/f;R26Rmutants and controls (Fig 4A and 4B). Next, we examined
whether cell proliferation was affected inWnt1-cre;Gsαf/f mutants. The CNCCs-derived
the mesoderm-derived otic capsule is normal in P0Wnt1-cre;Gsαf/fmutant (N). agp, angular process; b-hy, body of the hyoid bone; bo, basioccipital; cdp,
condylar process; crp, coronoid process; eo, exoccipital; fr, frontal; gh-hy, greater horn of the hyoid bone; ip, interparietal; lh-hy, lesser horn of the hyoid bone;
ma, mandible; mx, maxilla; na, nasal bone; nc, nasal capsule; oc, otic capsule; pmx, premaxilla; pr, parietal; rpMC, rostral process of Meckel’s cartilage; so,
supraoccipital; th, thyroid cartilage; tr, tympanic ring.
doi:10.1371/journal.pone.0147535.g002
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Fig 3. Wnt1-cre;Gsαf/fmutants exhibit cleft palate. (A, B) Ventral view of palates after removal of mandible
in P0Wnt1-cre;Gsαf/fmutant and control. Fused palate in control (B), but cleft palate inGsα knockout mice
(A, arrow). (C-H) H&E staining of head coronal sections inWnt1-cre;Gsαf/fmutants and controls from different
Gsα and Craniofacial Morphogenesis
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mesenchymal cell proliferation rate within craniofacial regions, as measured by BrdU incorpo-
ration, was identical between E13.5Wnt1-cre;Gsαf/f mutants and controls (Fig 4C and 4D).
Therefore, these results suggest that specific deletion of Gsα in NCCs has no effect on migra-
tion or proliferation of CNCCs.
Specific deletion ofGsα in NCCs leads to accelerated
osteochondrogenic differentiation
It has been demonstrated that craniofacial bones are more commonly generated through intra-
membranous ossification, in which neural crest-derived mesenchymal cells within craniofacial
connective tissues aggregate into blastema and then directly differentiate into osteoblasts with-
out cartilage templates [25,26]. Next, we performed Von Kossa staining to assess the ossifica-
tion process. Histological analysis showed comparable condensation of mesenchymal cells in
E12.5Wnt1-cre;Gsαf/f mutant and control (Fig 5A and 5B); however, from E14.5 to E17.5, the
ossification region was significantly increased inWnt1-cre;Gsαf/fmutants compared to controls
(Fig 5C–5H). In addition, abnormal ossification and malformed cartilage were observed in the
nasal septum of E17.5Wnt1-cre;Gsαf/f mutant (Fig 5I–5L).
Next, to investigate whether the abnormal ossification of mesenchymal cells and nasal carti-
lage malformation inWnt1-cre;Gsαf/f mutants were due to abnormal osteochondrogenic differ-
entiation, we analyzed the expression levels of genes that required for osteochondrogenic
differentiation in mandible and maxilla tissues. The mRNA level of ALP (an early osteoblastic
differentiation marker) and Runx2 (an osteogenic differentiation transcription factor) were
both significantly increased, while osteocalcin (a late marker for terminally differentiated osteo-
blast) was decreased inWnt1-cre;Gsαf/f mutants relative to controls (Fig 6A), suggesting that
Gsα deficiency accelerates osteogenic differentiation but inhibits osteoblast maturation.
Although there was no difference in the mRNA level of chondrocytic gene Sox9 between
Wnt1-cre;Gsαf/f mutants and controls, the expression of Col2a1 (a marker for proliferative
chondrocytes) was decreased, and ColX (a marker for differentiated chondrocytes) was
markedly increased inWnt1-cre;Gsαf/f mutants (Fig 6A), suggesting that Gsα deficiency inhib-
its chondrocytes proliferation but accelerates chondrogenic differentiation. Previous study
showed that Indian hedgehog (Ihh) and parathyroid hormone related protein (PTHrP) signal-
ing form a negative feedback loop to maintain chondrocyte proliferation and inhibit hypertro-
phic differentiation [27,28,29,30,31]. It has been reported that Gsα negatively regulates
chondrocyte differentiation and is the major mediator of PTHrP signaling [19]. To further
explain the effect of Gsα deficiency in chondrocytes, we analyzed the expression of PTHrP,
PPR (receptor for PTHrP) and Ihh. Results showed that PTHrP and PPR were up-regulated,
and Ihh was down-regulated inWnt1-cre;Gsαf/f mutants (Fig 6A), suggesting that loss of Gsα
affected the Ihh-PTHrP signaling. Hand2 and Twist1 are known regulators of Runx2 [32,33],
we found the expression of these two factors were significantly up-regulated inWnt1-cre;Gsαf/f
mutants. Furthermore, the protein expression of Runx2 and Sox9 was confirmed by western
blot, results revealed that Runx2 was up-regulated and Sox9 was down-regulated in the
embryonic stages. The palatal shelves grow vertically at two sides of tongue at E12.5 and E13.5 (C-F); and
then the palatal shelves have been elevated horizontally above the tongue and fused with remnant medial
edge epithelium in control at E14.5 (H, arrow), however they fail to fuse and a cleft was observed inWnt1-cre;
Gsαf/fmutant (G, asterisk), the initiation of palatal bone formation are indicated by arrowheads in (G and H).
(I-L) The palatal shelves have completely fused with flat tongues and disappearance of midline epithelium in
E16.5 and E18.5 controls (J and L), in contrast to the cleft palates with arched tongues inWnt1-cre;Gsαf/f
mutants (I and K). (M, N) In vitro organ culture showsWnt1-cre;Gsαf/fmutant palatal shelves are able to fuse,
asterisk indicates the disappearance of midline epithelium. P, palate; T, tongue.
doi:10.1371/journal.pone.0147535.g003
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Fig 4. Conditional deletion ofGsα in NCCs does not affect neural crest migration or cell proliferation.
(A, B) Whole-mount X-gal staining of E9.5 and E14.5 embryos. Normal distribution of migratory neural crest
cells inWnt1-cre;Gsαf/fmutants. FNP (asterisk), BA1 (arrow) and BA2 (arrowhead). (C, D)
Gsα and Craniofacial Morphogenesis
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craniofacial tissues ofWnt1-cre;Gsαf/fmutants (Fig 6B). Together these results suggest that
osteochondrogenic differentiation is accelerated inWnt1-cre;Gsαf/f mutants.
Furthermore, to examine whether Gsα directly regulates osteochondrogenic differentiation,
primary craniofacial mesenchymal cells were cultured and induced to initiate osteochondro-
genic differentiation in medium with β-glycerophosphate and ascorbic acid [34,35]. The chon-
drogenic and osteogenic differentiation were assessed at indicated days by Alcian Blue and
Alizarin Red staining respectively. As shown in Fig 6C, Gsα-deficient cells exhibited more carti-
lage matrix depositions and mineralized matrix depositions than control cells. Interestingly, we
found that from induced day 7 almost all Gsα-deficient cells accumulated gradually to form a
cell mass, and these cell mass showed extensive Alcian Blue or Alizarin Red staining, but none
in control cells (S3 Fig, 8 out of 9 inWnt1-cre;Gsαf/f mutants, none in 10 controls). This in
vitro culture process resembled the mesenchymal condensation in vivo, suggesting that osteo-
chondrogenic differentiation is accelerated inWnt1-cre;Gsαf/f mutants. Taken together, our
data indicate that specific deletion of Gsα in NCCs leads to accelerated osteochondrogenic
differentiation.
The cAMP response element binding protein (CREB) mediates-PTH signaling and bone
morphogenetic protein (BMP) signaling have been demonstrated to regulate osteoblast differ-
entiation and bone formation [36,37,38,39,40,41]. To determine whether these signaling path-
ways were affected by Gsα deficiency, we examined the expression of downstream protein in
dissected mandible and maxilla tissues by immunoblotting. InWnt1-cre;Gsαf/f mutants, the
phosphorylation of CREB (P-CREB), and the phosphorylation of smad2 and smad5 (P-Smad2
and P-Smad5), were down-regulated (Fig 6D). These results suggest that loss of Gsα in NCCs
leads to impaired CREB and BMP signaling.
Discussion
It has been suggested that Gsα signaling plays an important role in craniofacial development.
Sakamoto et al. found that specific deletion of Gsα in differentiated osteoblasts using collagen
Iα1-cre resulted in hypoplastic craniofacial bones and a 58% penetrance of cleft palate pheno-
type [21], and chondrocyte-specific Gsα ablation mice exhibited cyanosis and domed skull
[19]. In our study, we generate neural crest cells-specific Gsα KOmice by usingWnt1cre-LoxP
system and investigate the role of Gsα in craniofacial development.Wnt1-cre;Gsαf/f mutants
are viable at birth but quickly become cyanotic and have feeding difficulties. All mutants die
within hours after birth and exhibit dramatic craniofacial deficiencies including domed skull,
malformed and shortened maxilla and mandible, cleft palate and craniofacial skeleton defects.
Further evidence indicates that accelerated osteochondrogenic differentiation lead to the cra-
niofacial skeletons defects, and consequently cause the cleft palate inWnt1-cre;Gsαf/f mutant.
Taken together, our study demonstrates that Gsα is required for cranial neural crest cells-
derived craniofacial development.
The GNAS gene mutations have been implicated in multiple human diseases. The activating
Gsαmutations lead to endocrine tumors, McCune–Albright syndrome (MAS), and fibrous
dysplasia of bone; the heterozygous loss-of-function in GNAS cause Albright hereditary osteo-
dystrophy (AHO), a syndrome characterized with short stature, brachydactyly, developmental
delay or mental deficits, facial defects such as orbital hypertelorism and depressed nasal bridge.
Immunofluorescent labeling (C) and quantification (D) of BrdU positive cells in coronal maxilla sections. At
least thirty-five sections were randomly selected from six pairs of E13.5Wnt1-cre;Gsαf/fmutants and controls.
n.s, no significant difference. BA1, first branchial arch; BA2, second branchial arch; FNP, frontonasal
prominence.
doi:10.1371/journal.pone.0147535.g004
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Fig 5. Loss ofGsα in NCCs results in abnormal ossification. (A-H) Von Kossa and nuclear red staining of
heads coronal sections inWnt1-cre;Gsαf/fmutants and controls from different embryonic stages. The
aggregated mesenchymal cell in maxilla are similar between E12.5Wnt1-cre;Gsαf/fmutant and control
(arrows in A and B); however, the ossification region in E14.5Wnt1-cre;Gsαf/fmutant is larger than that in
control (arrows in C and D), and this phenotype are much more severe at later embryonic stages (arrows in
E-H). (I-L) Von Kossa staining (I, J) and alcian blue staining (K, L) show the abnormal ossification and
malformation of nasal septum cartilage in E17.5Wnt1-cre;Gsαf/fmutants (arrows in I and K).
doi:10.1371/journal.pone.0147535.g005
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The maternal inheritance of Gsαmutations cause AHO with multihormone resistance [termed
pseudohypoparathyroidism type IA (PHPIA)], and the paternal inheritance of Gsαmutations
only lead to AHO phenotype [termed pseudopseudohypoparathyroidism (PPHP)] [11,17].
Recently, a research group reported that a 6-month-old patient with PHPIA caused by GNAS
mutation had round face and craniosynostosis, which is characterized by synostosis of the cor-
onal, frontal, and sagittal sutures [42]. Interestingly,Wnt1-cre;Gsαf/f mutants show round face
Fig 6. Loss ofGsα in NCCs leads to accelerated osteochondrogenic differentiation. (A) RT-qPCR analysis of relative mRNA levels in E16.5 isolated
mandible and maxilla tissues. Data shown are normalized ratio ofWnt1-cre;Gsαf/f/Control (mean±SEM); student’s t-test; *p < 0.05; **p <0.01; ***p <0.001;
n6. (B) Western blot analysis of protein expression of Gsα, Runx2 and Sox9 in E16.5 isolated mandible and maxilla tissues. Data shown are from 3 pairs of
mutants and controls. (C) Alcian Blue and Alizarin Red staining show accelerated in vitro chondrogenic and osteogenic differentiation inWnt1-cre;Gsαf/f
mutant cells. Craniofacial mesenchymal cells fromWnt1-cre;Gsαf/fmutants and controls were subjected to osteochondrogenic differentiation in
differentiation medium (complete medium supplemented with 10mM β-glycerophosphate, 50 μg/ml ascorbic acid and 2.5 μM retinoic acid) for indicated days.
(D) Western blot analysis of protein expression of Gsα, P-CREB, CREB, P-Smad2 and P-Smad5 in E16.5 isolated mandible and maxilla tissues. Data shown
are from 3 pairs of mutants and controls.
doi:10.1371/journal.pone.0147535.g006
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(Fig 1K), shortened snout (Fig 1G, 1I and 1K), hypertelorism (Fig 1G) and craniosynostosis
(Fig 2A), these phenotypes are highly similar to the clinical phenotypes observed in GNAS
mutations diseases.
During the development of mouse embryos, the formation of palate contains multistep,
including extension, elevation and fusion of palatal shelves. In detail, palatal shelves arise from
maxillary prominence at E12.5 and grow vertically down to the two sides of tongue at E13.5;
subsequently, the bilateral shelves elevate horizontally and meet at the midline, then followed
by the fusion occurred between E14.5 and E15.5 [43,44]. In light of this process, cleft palate
could result from intrinsic defects within palate, such as deficiencies in palatal mesenchyme
cells proliferation and palatal epithelium fusion, or a secondary consequence of other craniofa-
cial malformations, such as hypoplastic mandible, physical obstruction of protuberant tongue
and palatal bone formation defect [45,46,47,48,49,50,51,52]. Since neural crest cells give rise to
the majority of mesenchyme cells within palate and craniofacial skeletons, it raises a question
that whether the cleft palate inWnt1-cre;Gsαf/f mutant results from a primary defect in palatal
development or is secondary to craniofacial skeletal defects. We further demonstrate that the
palatal shelves fromWnt1-cre;Gsαf/f mutant retain the ability to fuse in vitro, and the deletion
of Gsα in palatal shelves by Nestin-cre does not cause cleft palate (data not shown). Addition-
ally, the protuberant tongue observed inWnt1-cre;Gsαf/f mutant may result from abnormal
ossification of hyoid bone and consequently lead to physical obstruction between palatal
shelves. Collectively, we conclude that Gsα signaling is required for the craniofacial skeleton
development and the cleft palate inWnt1-cre;Gsαf/fmutant is caused by craniofacial skeletal
defects.
Endothelin receptors, including Endothelin-A (ETA) and Endothelin-B (ETB), are G-pro-
tein-coupled receptors (GPCR), and signals via ETA and ETB can be transmitted by G-proteins,
Gq, Gi, and/or Gs class. Target deletion of ETA, or its ligand endothelin-1 (ET-1), or endothelin
converting enzyme-1 (ECE-1) causes cleft palate and abnormal craniofacial bones
[53,54,55,56,57]. It has been shown that Gαq/Gα11 proteins mediate ET-1 signaling in pharyn-
geal arch mesenchyme [58], and neural crest-specific deletion of Gαq/Gα11 results in craniofa-
cial defects similar to those observed in mice lacking ETA or ET-1 [59]. Interestingly,
inactivation of Gα12/Gα13 in neural crest cells resulted in cardiac malformations but the head
morphology is grossly normal. In our study, neural crest-specific deletion of Gsα results in cra-
niofacial abnormalities which are different from ETA, ET-1, Gαq/Gα11, or Gα12/Gα13 knock-
out mice. These results suggest that the activating pathways for Gsα signaling in regulating
NCC development are different from that for Gαq/Gα11 or Gα12/Gα13 signaling. Previous
studies indicate that Hand2 and Twist1 can negatively regulate Runx2 activity and control
mandibular ossification, the reducing of Twist1 or Hand2 levels causes the premature ossifica-
tion and closure of the cranial sutures [32,33,60,61]. Interestingly, premature ossification of
mandible and craniosynostosis phenotypes inWnt1-cre;Gsαf/f mutants are similar to those
observed inHand2 and Twist1mutant mice. Moreover, Runx2, an obligatory ossification fac-
tor, is significantly increased in mandible and maxilla tissues ofWnt1-cre;Gsαf/fmutants. In
order to explain this premature ossification phenotype, we examine the expression of Hand2
and Twist1. Intriguingly, these two factors are both increased in the mandible tissues of
Wnt1-cre;Gsαf/f mutants, suggesting that the molecular mechanism for Runx2 upregulation in
Gsαmutants may be independent of Hand2 and Twist1.
During craniofacial skeleton development, CNCCs populate into FNP and BA regions, then
proliferate and differentiate into mesenchymal cells, and ultimately develop into bones and car-
tilages [62,63,64]. Precise coordination of NCCs migration, proliferation, and differentiation is
essential for craniofacial skeleton development. Our data show that NCCs-specific ablation of
Gsα has no effect on CNCCs migration or cell proliferation (Fig 4), but significantly accelerate
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the osteochondrogenic differentiation (Figs 5 and 6 and S3 Fig). Previous reports have revealed
the function of Gsα signaling in regulating chondrocyte and osteoblast differentiation. The acti-
vating Gsαmutations inhibit osteoblast differentiation [65,66,67] and the differentiation from
proliferating to hypertrophic chondrocytes [68]. Conversely, the inactivating Gsαmutations
may promote osteoblast differentiation [11,69] and chondrocyte differentiation within growth
plate [70,71,72]. Furthermore, both the Gnas KOmice and chondrocyte-specific Gsα KOmice
show accelerated hypertrophic differentiation of growth plate chondrocytes and upregulation
of PTHrP [12,19,73], and ablation of Gsα in early osteoblast lineage results in accelerated osteo-
genic differentiation [20]. Our results show that the expression of ColX, a marker for hypertro-
phic chondrocytes, is significantly increased inWnt1-cre;Gsαf/f mutants (Fig 6A), this result is
in line with previous evidence that Gsα is a negative regulator of chondrocyte differentiation
[12,19,73]. It has been reported that Ihh-PTHrP form a negative feedback loop to regulate
chondrocyte proliferation and differentiation, by which Ihh activates the expression of PTHrP
in periarticular chondrocytes and PTHrP inhibits the expression of Ihh in proliferating chon-
drocytes [27,28,29,30,31]. Previous study with chondrocytes in vitro also suggested PTH/
PTHrP receptors may regulate expression of Col X [74]. Our data show that an increase of
PTHrP and PPR, and a decrease of Ihh in the craniofacial tissues ofWnt1-cre;Gsαf/f mutants.
These results are consistent with previous data that Gsα negatively regulates chondrocyte dif-
ferentiation and is the major mediator of Ihh-PTHrP signaling. The inactivation of Gsα in cal-
varial osteoblasts resulted in the up-regulation of ALP [21], and osteoblast/osteocyte-specific
ablation of Gsα decreased the expression of osteocalcin in skull bone samples [20]. Our results,
consistent with these findings, reveal that NCCs-specific Gsα deficiency strikingly increases
ALP and decrease osteocalcin (Fig 6A).
What is the molecular mechanism of Gsα regulating osteochondrogenic differentiation? Wu
et al. reported that Gsα deficiency in early osteoblast lineage reduced the commitment of mes-
enchymal progenitors to osteoblast lineage via suppressing Wnt signaling; in addition, they
reported accelerated differentiation of osteoblasts into osteocytes in Gsα deficiency mice, but
the molecular mechanism of Gsα underlying the regulation of this differentiation process
remained unclear [20]. The phenotype inWnt1-cre;Gsαf/f mutants resembles that in PTH-/-
mice [71,75,76]. It has been revealed that BMP signaling and CREB mediates PTH signaling
both play critical roles in regulating osteoblast differentiation and bone formations
[36,37,38,39,40,41]. Recently, a study demonstrated that PTH-CREB signaling pathway func-
tioned as an effective activator of BMP2 expression [77]. Our data show that P-CREB, a down-
stream transcriptional factor for Gsα-cAMP-PKA, and P-Smad2 and P-Smad5, the
downstream signaling effectors for TGF-β and BMP respectively, are suppressed by loss of Gsα
(Fig 6D). These results suggest that Gsα regulating osteochondrogenic differentiation may be
attributed to CREB and BMP signaling, but the detailed molecular mechanism need to be fur-
ther deciphered. Since the craniofacial phenotypes exhibit some differences betweenWnt1-cre;
Gsαf/f mutants and PTH-/-mice, there might exist other possibilities for Gsα regulating cranio-
facial development. Regard et al. found that Wnt/β-catenin signaling is regulated by Gsα pro-
teins during both skeletal development and fibrous dysplasia disease [78] andWnt/β-catenin
signaling has been shown to regulate the craniofacial morphogenesis [79,80]. It would be inter-
esting to investigate the underlying relationship of Gsα, Wnt/β-catenin, TGF-β and BMP sig-
naling in craniofacial development.
In conclusion, our results demonstrate that Gsα signaling is required for the neural crest
cells-derived craniofacial morphogenesis. Conditional deletion of Gsα in neural crest cells
results in accelerated osteochondrogenic differentiation and eventually leads to craniofacial
malformations.
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Materials and Methods
Animals
All mice were housed in a specific pathogen-free facility, and all experiments were conducted
in accordance with the guidelines and under the approval of the Animal Care Committees at
Sichuan University. Gsαflox/flox mice andWnt1-cre transgenic mice have been described previ-
ously [22,23]. Gsαflox/flox mice were crossed with Wnt1-cre mice to obtain theWnt1-cre;Gsαf/+
heterozygous, the tissue-specific Gsα knockout mice (Wnt1-cre;Gsαf/f) were obtained from the
crosses between Gsαflox/flox mice andWnt1-cre;Gsαf/+ heterozygous.Wnt1-cre;Gsαf/+ heterozy-
gous had no obvious phenotype. Gsαflox/flox and Gsαflox/+ were used as controls except where
otherwise specified. These mice were genotyped by PCR using genomic DNA isolated from
tails, primers were listed as in Table 1.
Skeleton staining
The skeletal preparation and Alizarin Red and Alcian Blue staining were performed according
to standard techniques with minor modifications [81]. Briefly, the embryos or neonates were
de-skinned and fixed in 100% ethanol overnight, then followed by 100% acetone to remove fat.
The skeleton was stained in Alcian Blue solution (150mg/L Alcian Blue 8 GX, 80% ethanol,
20% acetic acid) for two days at 37°C, then washed in 95% ethanol for 8–12 hours and cleared
in 2% KOH solution for 24 hours, followed by staining in Alizarin Red solution (50mg/L Aliza-
rin Red in 2% KOH) for 24 hours. Finally, the skeletons were cleared in water and stored in
20% glycerol.
Histological analysis
Mouse embryos were fixed in 4% paraformaldehyde, washed and cryoprotected in 30% sucrose
then embedded in OCT (Tissue-tek), and sectioned at 14 μm. Haematoxylin and eosin (H&E)
staining, Von Kossa staining and nuclear red staining were performed following standard
procedures.
Whole-mount X-Gal staining
β-galactosidase expression was detected by X-Gal staining. Embryos were fixed in 4% parafor-
maldehyde, the staining procedure was performed using the Senescence β-Galactosidase Stain-
ing Kit (Beyotime), following the manufacturer’s recommendations.
Whole-mount immunohistological staining
Whole-mount immunohistological staining was performed as previously described [82]. Anti-
2H3 antibody (Hybridoma Bank) was used at a concentration of 1:50.
Table 1.
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Cell proliferation assay
To detect proliferating cells, pregnant mice were injected intraperitoneally with BrdU
(5-bromo-2’-deoxy-uridine, 50 μg/g body weight) for 1.5 hours before harvesting embryos.
Frozen sections were treated with 2N HCl at 37°C for 20 min then incubated with anti-BrdU
antibody (Santa Cruz, #sc32323, 1:200) and DAPI. BrdU positive and DAPI positive cells were
automatically counting using Image Pro Plus, and percentage of BrdU+ / DAPI+ cells was used
as proliferation rate.
Palatal shelves culture
Palatal shelves culture was performed as previously described [83,84,85]. Briefly, palatal shelves
were dissected from E13.5 embryos and placed on Millipore filters keeping the two segments
touching at the medial edge, cultured for 72 hours and fixed in 4% paraformaldehyde then fol-
lowed by histological H&E staining.
Cell culture
Primary craniofacial mesenchymal cell culture and osteochondrogenic differentiation were
performed as previously described with minor modification [35,86]. In brief, maxilla was dis-
sected from E13.5 embryos and digested with 0.25% trypsin at 37°C for 30 min, then pipette
thoroughly in DMEM containing 10% FBS. Cells were initially seeded at a density of 3 x 104
cell/cm2 and cultured in complete medium (DMEM containing 10% FBS supplemented with
penicillin, streptomycin, L-glutamate and sodium pyruvate). After 24 hours (Day 0), complete
medium was replaced by differentiation medium (complete medium supplemented with
10mM β-glycerophosphate, 50 μg/ml ascorbic acid and 2.5 μM retinoic acid) to induce chon-
drogenic and osteogenic differentiation. Followed by indicating days, cells were fixed and
stained with Alcian blue and Alizarin red as previously described [34,35].
Real-time quantitative PCR
Total RNA was isolated using the RNeasy kit (QIAGEN, #74134), and cDNA was synthesized
with the TransScript One-Step gDNA Removal and cDNA Synthesis SuperMix (Transgen,
#AT311). Quantitative real-time PCR (qPCR) was performed using SYBR Green PCRMaster
Table 2.
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Mix (Applied Biosystems, #4367659). Expression levels of mRNA were normalized to β-actin,
primer sequences used for qPCR were according to previously published results [20,87], listed
as in Table 2.
Statistical analysis
Statistical analysis was performed using two-tailed Student’s t test. Data are presented as mean
±SEM; P<0.05 indicated significant difference.
Supporting Information
S1 Fig. The gross morphologies of craniofacial nerve and cardiac outflow tract are normal
inWnt1-cre;Gsαf/f mutants. (A-D) Whole-mount staining of anti-neurofilament marker 2H3
in E10.5 (A, B) and E12.5 (C, D) embryos. (E, F) Whole-mount X-gal staining of heart in E17.5
Wnt1-cre;Gsαf/f mutant and control.
(TIF)
S2 Fig. Impaired development of DRG and sympathetic ganglia inWnt1-cre;Gsαf/f;R26R
mutants. (A-F) Lateral view of whole-mount X-gal staining of dorsal root ganglion in E15.5
(A, B), E16.5 (C, D) and E17.5 (E, F)Wnt1-cre;Gsαf/f mutants and controls. (G-J) Ventral view
of whole-mount X-gal staining of sympathetic ganglion in E15.5 (G, H) and E17.5 (I, J)
Wnt1-cre;Gsαf/f mutants and controls.
(TIF)
S3 Fig. Loss of Gsα in NCCs leads to accelerated osteochondrogenic differentiation. Alcian
Blue and Alizarin Red staining show accelerated in vitro chondrogenic and osteogenic differen-
tiation and cell accumulation inWnt1-cre;Gsαf/f mutant cells. All pictures are from three inde-
pendent experiments,Wnt1-cre;Gsαf/f mutants (n = 9), controls (n = 10).
(TIF)
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